Clinical Trials

GastrointestinalGynecologic

17 enrolled

Colonic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms, Microsatellite Instability

NCT04294160 2025-12-24

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

122 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT05010850 2025-07-03

SAFE-2

18 enrolled 10 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT01605318 2024-01-24

Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer

92 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01347645 2023-06-22

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

82 enrolled 14 charts

Colonic Neoplasms, Rectal Neoplasms

NCT02933944 2022-01-26

Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer

6 enrolled 11 charts

Rectal Neoplasms

NCT02465593 2022-01-11

A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer

32 enrolled

Rectal Neoplasms

NCT00041691 2021-08-19

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery

30 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02205307 2020-06-24

PILLAR III

347 enrolled 18 charts

Rectal Neoplasms

NCT01609231 2020-05-04

MK-0646-025

Phase 2 Terminated

11 enrolled 8 charts

Rectal Neoplasms

NCT02425683 2020-02-10

Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX

Phase 2 Terminated

24 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02205398 2019-01-22

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

GastrointestinalHead & Neck

13 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00816777 2018-09-07

PARAGON

4 enrolled 5 charts

Carcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00663819 2018-04-17

Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses

258 enrolled 10 charts

Colitis, Ulcerative, Diverticulitis, Adenomatous Polyposis Coli, Rectal Neoplasms

NCT02407561 2018-01-25

Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays

Terminated

3 enrolled

Adenocarcinoma, Anus Neoplasms, Rectal Neoplasms

NCT01717014 2015-03-02

Radial Reload Open LAR Case Series

8 enrolled 15 charts

Rectal Neoplasms

NCT00006269 2012-05-25

Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

Phase 3 Terminated

89 enrolled

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

NCT00259363 2009-12-07

Oxaliplatin in Rectal Cancer

46 enrolled